Charles A. Sanders
In 2005 Charles A. Sanders was "appointed Chairman of Board of Directors for Icagen Inc. Dr. Sanders M.D. has served on the Board since 1997. His appointment follows the resignation from Icagen's Board of H. Jefferson Leighton, Ph.D., who has served as Chairman since 1992.
"Dr. Sanders has over forty years of experience in the pharmaceutical industry and academic medicine. Dr. Sanders served as chairman and chief executive officer of Glaxo Inc. from 1989 to May 1995, and also served as a member of the board of directors of Glaxo plc. Previously, Dr. Sanders was general director of Massachusetts General Hospital and professor of medicine at Harvard Medical School. Dr. Sanders is a director of several publicly traded companies, including Trimeris, Genentech and Fisher Scientific International. He is currently a member of the Institute of Medicine of the National Academy of Sciences, a member of the CSIS Board of Trustees, chairman of Project HOPE and chairman of the Foundation for the National Institutes of Health. Dr. Sanders is also past chairman of the New York Academy of Sciences, past chairman of The Commonwealth Fund and past chairman of the Harvard Overseers Committee to Visit the Harvard Medical School. Dr. Sanders received his M.D. from Southwestern Medical College of the University of Texas." 
"Before joining Glaxo Inc. Sanders spent eight years with Squibb Corp., where he held a number of posts, including the position of vice chairman."